Q5155 Injection, aflibercept-jbvf, 1 milligrams
Q-Codes
Also known as: aflibercept biosimilar, Fabhalta, anti-VEGF, VEGF inhibitor
Injection of aflibercept-jbvf (Fabhalta), a biosimilar to aflibercept, administered at 1 milligram per dose.
Clinical Context
Used for neovascular age-related macular degeneration with intravitreal administration every 4-8 weeks. Inhibits angiogenesis in retinal disease.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.